Bank Of New York Mellon Corp Akero Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$17.76 - $31.18 $203,369 - $357,042	11,451 Added 6.44%	189,246 $4.78 Billion
Q4 2023 Jan 29, 2024	SELL	$11.38 - $50.33 $3.67 Million - $16.2 Million	-322,450 Reduced 64.46%	177,795 $4.15 Billion
Q3 2023 Oct 24, 2023	BUY	$41.19 - $52.25 $14.3 Million - $18.1 Million	346,317 Added 224.99%	500,245 $25.3 Billion
Q2 2023 Aug 03, 2023	BUY	$36.89 - $56.88 $1.16 Million - $1.78 Million	31,336 Added 25.56%	153,928 $7.19 Billion
Q1 2023 May 09, 2023	BUY	$37.27 - $50.24 $4.57 Million - $6.16 Million	122,592 New	122,592 $4.69 Billion
Q4 2022 Feb 14, 2023	BUY	$33.44 - $54.8 $4.7 Million - $7.7 Million	140,482 New	140,482 $7.7 Million
Q3 2022 Nov 14, 2022	BUY	$10.15 - $34.05 $272,151 - $912,982	26,813 Added 31.15%	112,890 $3.84 Million
Q2 2022 Aug 15, 2022	BUY	$8.0 - $15.01 $35,960 - $67,469	4,495 Added 5.51%	86,077 $814,000
Q1 2022 May 11, 2022	BUY	$12.97 - $22.26 $36,225 - $62,172	2,793 Added 3.54%	81,582 $1.16 Million
Q4 2021 Feb 11, 2022	BUY	$19.87 - $26.24 $33,282 - $43,952	1,675 Added 2.17%	78,789 $1.67 Million
Q3 2021 Nov 12, 2021	BUY	$18.65 - $25.46 $137,879 - $188,225	7,393 Added 10.6%	77,114 $1.72 Million
Q2 2021 Aug 11, 2021	BUY	$24.81 - $32.35 $373,961 - $487,611	15,073 Added 27.58%	69,721 $1.73 Million
Q1 2021 May 13, 2021	SELL	$24.04 - $34.19 $134,239 - $190,916	-5,584 Reduced 9.27%	54,648 $1.59 Million
Q4 2020 Feb 09, 2021	SELL	$25.12 - $29.89 $268,683 - $319,703	-10,696 Reduced 15.08%	60,232 $1.55 Million
Q3 2020 Nov 12, 2020	BUY	$30.79 - $39.92 $931,089 - $1.21 Million	30,240 Added 74.32%	70,928 $2.18 Million
Q2 2020 Aug 12, 2020	BUY	$19.25 - $26.76 $254,716 - $354,088	13,232 Added 48.19%	40,688 $1.01 Million
Q1 2020 May 06, 2020	BUY	$12.8 - $27.05 $108,646 - $229,600	8,488 Added 44.75%	27,456 $582,000
Q4 2019 Feb 14, 2020	BUY	$17.37 - $27.27 $138,977 - $218,187	8,001 Added 72.96%	18,968 $421,000
Q3 2019 Nov 07, 2019	BUY	$16.89 - $29.88 $185,232 - $327,693	10,967 New	10,967 $249,000

Others Institutions Holding AKRO

# of Institutions

190

Shares Held

73.8M

Call Options Held

241K

Put Options Held

647K

Wellington Management Group LLP Boston, MA

7.9M
Shares

$221 Million
0.04% of portfolio
Janus Henderson Group PLC London, X0

7.08M
Shares

$198 Million
0.11% of portfolio
Rtw Investments, LP New York, NY

5.92M
Shares

$166 Million
2.71% of portfolio
Black Rock Inc. New York, NY

5.59M
Shares

$156 Million
0.0% of portfolio
General Atlantic LLC New York, NY

5.23M
Shares

$146 Million
4.29% of portfolio

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.3B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account